Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 46
Filtrar
Más filtros

Intervalo de año de publicación
1.
Curr Top Microbiol Immunol ; 400: 277-304, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28124158

RESUMEN

Gastric cancer is the fifth most incident and the third most common cause of cancer-related death in the world. Infection with Helicobacter pylori is the major risk factor for this disease. Gastric cancer is the final outcome of a cascade of events that takes decades to occur and results from the accumulation of multiple genetic and epigenetic alterations. These changes are crucial for tumor cells to expedite and sustain the array of pathways involved in the cancer development, such as cell cycle, DNA repair, metabolism, cell-to-cell and cell-to-matrix interactions, apoptosis, angiogenesis, and immune surveillance. Comprehensive molecular analyses of gastric cancer have disclosed the complex heterogeneity of this disease. In particular, these analyses have confirmed that Epstein-Barr virus (EBV)-positive gastric cancer is a distinct entity. The identification of gastric cancer subtypes characterized by recognizable molecular profiles may pave the way for a more personalized clinical management and to the identification of novel therapeutic targets and biomarkers for screening, prognosis, prediction of response to treatment, and monitoring of gastric cancer progression.


Asunto(s)
Infecciones por Virus de Epstein-Barr/genética , Infecciones por Virus de Epstein-Barr/patología , Infecciones por Helicobacter/genética , Infecciones por Helicobacter/patología , Helicobacter pylori/fisiología , Neoplasias Gástricas/genética , Neoplasias Gástricas/patología , Animales , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Progresión de la Enfermedad , Infecciones por Virus de Epstein-Barr/microbiología , Infecciones por Virus de Epstein-Barr/virología , Infecciones por Helicobacter/microbiología , Infecciones por Helicobacter/virología , Helicobacter pylori/genética , Herpesvirus Humano 4/genética , Herpesvirus Humano 4/aislamiento & purificación , Herpesvirus Humano 4/fisiología , Humanos , Estómago/microbiología , Estómago/patología , Estómago/virología , Neoplasias Gástricas/microbiología , Neoplasias Gástricas/virología
2.
Ann Oncol ; 28(9): 2086-2093, 2017 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-28911061

RESUMEN

The International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI) have initiated a series of cancer-focused seminars [Scelo G, Hofmann JN, Banks RE et al. International cancer seminars: a focus on kidney cancer. Ann Oncol 2016; 27(8): 1382-1385]. In this, the second seminar, IARC and NCI convened a workshop in order to examine the state of the current science on esophageal squamous cell carcinoma etiology, genetics, early detection, treatment, and palliation, was reviewed to identify the most critical open research questions. The results of these discussions were summarized by formulating a series of 'difficult questions', which should inform and prioritize future research efforts.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias Esofágicas , Internacionalidad , Carcinoma de Células Escamosas/epidemiología , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/terapia , Detección Precoz del Cáncer , Neoplasias Esofágicas/epidemiología , Neoplasias Esofágicas/genética , Neoplasias Esofágicas/terapia , Carcinoma de Células Escamosas de Esófago , Humanos , Factores de Riesgo
3.
Genes Immun ; 16(8): 567-70, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26312625

RESUMEN

A genome-wide association study among Europeans related polymorphisms of the Toll-like receptor (TLR) locus at 4p14 and the Fcγ receptor 2a locus at 1q23.3 to Helicobacter pylori serologic status. We replicated associations of 4p14 but not 1q23.3 with anti-Helicobacter pylori antibodies in 1402 Finnish males. Importantly, our analysis clarified that the phenotype affected by 4p14 is quantitative level of these antibodies rather than association with seropositivity per se. In addition, we annotated variants at 4p14 as expression quantitative trait loci (eQTL) associated with TLR6/10 and FAM114A1. Our findings suggest that 4p14 polymorphisms are linked to host immune response to H. pylori infection but not to its acquisition.


Asunto(s)
Infecciones por Helicobacter/genética , Infecciones por Helicobacter/inmunología , Helicobacter pylori/fisiología , Sitios de Carácter Cuantitativo , Receptor Toll-Like 10/genética , Receptor Toll-Like 6/genética , Anticuerpos Antibacterianos/genética , Anticuerpos Antibacterianos/inmunología , Finlandia , Estudio de Asociación del Genoma Completo , Humanos , Masculino , Polimorfismo Genético , Receptor Toll-Like 10/inmunología , Receptor Toll-Like 6/inmunología
5.
Br J Cancer ; 105(1): 38-43, 2011 Jun 28.
Artículo en Inglés | MEDLINE | ID: mdl-21654677

RESUMEN

BACKGROUND: Meta-analyses of the published literature indicate that about 9% of gastric cancers contain Epstein-Barr virus (EBV), with consistent and significant differences by sex and anatomic subsite. This study aimed to identify additional determinants of EBV positivity and their joint effects. METHODS: From 15 international populations with consistent laboratory testing for EBV, we pooled individual-level data for 5081 gastric cancer cases including information on age, sex, subsite, histologic type, diagnostic stage, geographic region, and period of diagnosis. First, we combined population-specific EBV prevalence estimates using random effects meta-analysis. We then aggregated individual-level data to estimate odds ratios of EBV positivity in relation to all variables, accounting for within-population clustering. RESULTS: In unadjusted analyses, EBV positivity was significantly higher in males, young subjects, non-antral subsites, diffuse-type histology, and in studies from the Americas. Multivariable analyses confirmed significant associations with histology and region. Sex interacted with age (P=0.003) and subsite (P=0.002) such that male predominance decreased with age for both subsites. The positivity of EBV was not significantly associated with either stage or time period. CONCLUSION: Aggregating individual-level data provides additional information over meta-analyses. Distinguishing histologic and geographic features as well as interactions among age, sex, and subsite further support classification of EBV-associated gastric cancer as a distinct aetiologic entity.


Asunto(s)
Adenocarcinoma/virología , Carcinoma de Células en Anillo de Sello/virología , Infecciones por Virus de Epstein-Barr/virología , Herpesvirus Humano 4/genética , Neoplasias Gástricas/virología , Adenocarcinoma/genética , Anciano , Carcinoma de Células en Anillo de Sello/genética , Infecciones por Virus de Epstein-Barr/genética , Femenino , Humanos , Agencias Internacionales , Masculino , Metaanálisis como Asunto , Persona de Mediana Edad , Pronóstico , Neoplasias Gástricas/genética
7.
Sci Rep ; 9(1): 20070, 2019 12 27.
Artículo en Inglés | MEDLINE | ID: mdl-31882676

RESUMEN

Helicobacter pylori (H. pylori) eradication using standard triple therapy (STT) with proton pump inhibitors (PPI), amoxicillin and clarithromycin (CLA) has been the standard in Latin America. However, CLA resistance is a rising problem affecting eradication rates. Genetic polymorphisms of CYP2C19, a PPI metabolizer may also affect eradication. The primary aims of this study were to evaluate the effect of clarithromycin resistance on H. pylori eradication in a population from Santiago, and to establish the pooled clarithromycin resistance in Santiago, Chile. Symptomatic adult patients attending a tertiary hospital in Santiago were recruited for this study. CLA resistance and the polymorphisms of CYP2C19 were determined on DNA extracted from gastric biopsies, using PCR. The STT was indicated for 14 days and eradication was determined by a urea breath test 4-6 weeks after therapy. A meta-analysis of CLA resistance studies among adult residents in Santiago was performed. Seventy-three out of 121 consecutive patients had positive rapid urease test (RUT) and received STT. Sixty-nine patients (95%) completed the study. The H. pylori eradication rate was 63% and the prevalence of CLA resistance was 26%. According to the CYP2C19 polymorphisms, 79.5% of the RUT-positive patients were extensive metabolizers. Multivariable analyses showed that only CLA resistance was significantly and inversely associated with failure of eradication (OR: 0.13; 95% confidence interval [95% CI], 0.04-0.49). A meta-analysis of two previous studies and our sample set (combined n = 194) yielded to a pooled prevalence of CLA resistance of 31.3% (95% CI 23.9-38.7). Our study shows that CLA resistance is associated with failure of H. pylori eradication. Given the high pooled prevalence of CLA resistance, consideration of CLA free therapies in Santiago is warranted. We could recommend bismuth quadruple therapy or high-dose dual therapy, according to bismuth availability. Further studies need to evaluate the best therapy.


Asunto(s)
Antibacterianos/farmacología , Claritromicina/farmacología , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori/efectos de los fármacos , Adulto , Bismuto/uso terapéutico , Chile/epidemiología , Estudios de Cohortes , Farmacorresistencia Bacteriana/efectos de los fármacos , Femenino , Infecciones por Helicobacter/epidemiología , Infecciones por Helicobacter/microbiología , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Prospectivos
8.
Aliment Pharmacol Ther ; 47(4): 494-503, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29243850

RESUMEN

BACKGROUND: Serum pepsinogen 1 (SPG1) and anti-Helicobacter pylori serology have been used for gastric risk stratification in Asia. AIM: To assess utility of these markers in a Western population. METHODS: SPG1 measurements were available for 21 895 Finnish male smokers in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. We used Cox proportional hazards models adjusted for potential confounders to estimate gastric cancer hazard ratios (HR) and 95% confidence intervals (95% CI) for low SPG1 (<25 µg/L). In a subset (n = 3555) with anti-H. pylori serology, these markers jointly defined the following: Group A (H. pylori[-], SPG1[normal]; reference group), Group B (H. pylori[+], SPG1[normal]), Group C (H. pylori[+], SPG1[low]) and Group D (H. pylori[-], SPG1[low]). Odds ratios (ORs) and 95% CI were calculated using multivariate logistic regression. RESULTS: There were 329 gastric cancers diagnosed an average of 13.9 years after baseline. Pre-diagnostic low SPG1 was significantly associated with increased gastric cancer risk (HR 2.68, 95% CI 1.99-3.61). Among subjects with both SPG1 and H. pylori serology, groups B, C and D had increased gastric cancer ORs (95% CI) of 1.79 (1.21-2.64), 3.85 (2.36-6.28) and 6.35 (2.20-18.34), respectively. CagA seropositives had significantly higher ORs than CagA seronegatives within group B (Pheterogeneity  = 0.01). For groups B and C, repeat SPG1 level at 3 years did not further stratify gastric cancer risk. CONCLUSIONS: Low SPG1 was associated with increased gastric cancer risk in our large Finnish cohort. A single measurement of SPG1 along with H. pylori whole cell and CagA serology provides potentially useful prediction of gastric cancer risk.


Asunto(s)
Anticuerpos Antibacterianos/sangre , Infecciones por Helicobacter/complicaciones , Infecciones por Helicobacter/diagnóstico , Helicobacter pylori/inmunología , Inmunoglobulina G/sangre , Pepsinógeno A/sangre , Neoplasias Gástricas/diagnóstico , Anciano , Biomarcadores/sangre , Estudios de Cohortes , Finlandia/epidemiología , Infecciones por Helicobacter/sangre , Infecciones por Helicobacter/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Ensayos Clínicos Controlados Aleatorios como Asunto , Sistema de Registros , Factores de Riesgo , Factores Sexuales , Neoplasias Gástricas/sangre , Neoplasias Gástricas/epidemiología , Neoplasias Gástricas/microbiología
9.
Rev Gastroenterol Mex (Engl Ed) ; 83(3): 325-341, 2018.
Artículo en Inglés, Español | MEDLINE | ID: mdl-29941237

RESUMEN

Important advances have been made since the last Mexican consensus on the diagnosis and treatment of Helicobacter pylori (H. pylori) infection was published in 2007. Therefore, the Asociación Mexicana de Gastroenterología summoned 20 experts to produce "The Fourth Mexican Consensus on Helicobacter pylori". From February to June 2017, 4 working groups were organized, a literature review was performed, and 3 voting rounds were carried out, resulting in the formulation of 32 statements for discussion and consensus. From the ensuing recommendations, it was striking that Mexico is a country with an intermediate-to-low risk for gastric cancer, despite having a high prevalence of H. pylori infection. It was also corroborated that peptic ulcer disease, premalignant lesions, and histories of gastric cancer and mucosa-associated lymphoid tissue lymphoma should be considered clear indications for eradication. The relation of H. pylori to dyspeptic symptoms continues to be controversial. Eradication triple therapy with amoxicillin, clarithromycin, and a proton pump inhibitor should no longer be considered first-line treatment, with the following 2 options proposed to take its place: quadruple therapy with bismuth (proton pump inhibitor, bismuth subcitrate, tetracycline, and metronidazole) and quadruple therapy without bismuth (proton pump inhibitor, amoxicillin, clarithromycin, and metronidazole). The need for antimicrobial sensitivity testing when 2 eradication treatments have failed was also established. Finally, the promotion of educational campaigns on the diagnosis and treatment of H. pylori for both primary care physicians and the general population were proposed.


Asunto(s)
Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Antibacterianos/uso terapéutico , Quimioterapia Combinada , Educación en Salud , Infecciones por Helicobacter/microbiología , Humanos , México , Médicos de Atención Primaria
10.
Braz J Med Biol Res ; 28(10): 1065-8, 1995 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8634678

RESUMEN

We compare the results obtained by counterimmunoelectrophoresis in samples of serum and cerebrospinal fluid with microbiologic methods for 3,298 patients suspected of bacterial meningitis and/or septicemia at Instituto Adolfo Lutz, São Paulo, in a retrospective study of the period from July 1998 to July 1994. Of the 415 patients (12.6% of the total cases studied) who were positive by the serum test, only 249 (7.6% of the total cases studied) were also positive when cerebrospinal fluid was assayed. Thus, 40% of the positives (5.6% of the total) were identifiable by analysis of serum but not of cerebrospinal fluid. Neisseria meningitidis accounted for 77.7% (129) and Haemophilus influenzae for 22.3% (37) of the positive results obtained only when serum was examined. These data show that although sensitivity and specificity of serum counterimmunoelectrophoresis are relatively low compared to cerebrospinal fluid counterimmunoelectrophoresis, the serum test is necessary to complement cerebrospinal fluid counterimmunoelectrophoresis data.


Asunto(s)
Antígenos Bacterianos/sangre , Contrainmunoelectroforesis , Meningitis Bacterianas/diagnóstico , Neisseria meningitidis/inmunología , Sepsis/diagnóstico , Antígenos Bacterianos/líquido cefalorraquídeo , Humanos , Meningitis Bacterianas/sangre , Meningitis Bacterianas/líquido cefalorraquídeo , Estudios Retrospectivos
11.
J Parasitol ; 89(4): 870-1, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-14533710

RESUMEN

Antibodies to Neospora caninum and Toxoplasma gondii were assayed in sera of 396 opossums (Didelphis marsupialis) from the city of São Paulo, Brazil. Antibodies to N. caninum were assayed using the indirect immunofluorescent antibody test (IFAT). Antibodies (IFAT, approximately 1:25) to N. caninum were found in 84 opossums (D. marsupialis) in titers of 1:25 in 46, 1:50 in 20, 1:100 in 17, and 1:400 in 1. Antibodies to T. gondii were assayed with the modified agglutination test (MAT) and the IFAT. Antibodies to T. gondii (MAT, approximately 1:25) were found in 82 (20.4%) of the 396 opossums, in titers of 1:25 in 24, 1:50 in 26, 1:100 in 18, 1:200 in 13, and 1:800 in 1. The IFAT antibodies to T. gondii were found in 148 of 396 opossums, in titers of 1:16 in 41, 1:32 in 23, 1:64 in 13, 1:128 in 6, 1:256 in 20, 1:512 in 17, 1:1,024 in 10, 1:2,048 in 10, 1:4,096 in 7, and 1:8,192 in 1. This is the first report of N. caninum and T. gondii infections in D. marsupialis.


Asunto(s)
Coccidiosis/veterinaria , Neospora/inmunología , Zarigüeyas/parasitología , Toxoplasma/inmunología , Toxoplasmosis Animal/epidemiología , Pruebas de Aglutinación/veterinaria , Animales , Anticuerpos Antiprotozoarios/sangre , Brasil/epidemiología , Coccidiosis/epidemiología , Técnica del Anticuerpo Fluorescente Indirecta/veterinaria , Estudios Seroepidemiológicos
12.
J Parasitol ; 88(6): 1251-2, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12537122

RESUMEN

Parasite Biology, Epidemiology and Systematics Laboratory, Animal and Natural Resources Institute, Agricultural Research Service, United States Department of Agriculture, Building 1001, Beltsville, Maryland 20705-2350 Antibodies to Neospora caninum and Sarcocystis neurona were determined in serum samples of 502 domestic cats from Brazil using direct agglutination tests with the respective antigens. Antibodies to S. neurona were not found in 1:50 dilution of any serum in the S. neurona agglutination test. suggesting that domestic cats from São Paulo city were not exposed to S. neurona sporocysts from opossums. Antibodies to N. caninum were found in 60 (11.9%) of 502 cats with titers of 1:40 in 36 cats, 1:80 in 18 cats, 1:160 in 5 cats, and 1:800 in 1 cat using the Neospora agglutination test (NAT). Antibodies to N. caninum were confirmed by Western blotting in the sera of 10 cats with NAT titers of 1:80 to 1:800; this finding suggests that at least 10 cats had N. caninum-specific antibodies confirmed by 2 tests. This is the first documentation of natural exposure of cats to N. caninum.


Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Enfermedades de los Gatos/epidemiología , Coccidiosis/veterinaria , Neospora/inmunología , Sarcocystis/inmunología , Sarcocistosis/veterinaria , Pruebas de Aglutinación/veterinaria , Animales , Western Blotting/veterinaria , Brasil/epidemiología , Enfermedades de los Gatos/inmunología , Gatos , Coccidiosis/epidemiología , Coccidiosis/inmunología , Sarcocistosis/epidemiología , Sarcocistosis/inmunología , Estudios Seroepidemiológicos
13.
Rev Inst Med Trop Sao Paulo ; 36(4): 373-6, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7732269

RESUMEN

The prevalence of rubella antibodies was evaluated through a random seroepidemiological survey in 1400 blood samples of 2-14 year old children and in 329 samples of umbilical cord serum. Rubella IgG antibodies were detected by ELISA, and the sera were collected in 1987, five years before the mass vaccination campaign with measles-mumps-rubella vaccine carried out in the city of São Paulo in 1992. A significant increase in prevalence of rubella infection was observed after 6 years of age, and 77% of the individuals aged from 15 to 19 years had detectable rubella antibodies. However, the seroprevalence rose to 90.5% (171/189) in cord serum samples from children whose mothers were 20 to 29 years old, and reached 95.6% in newborns of mothers who were 30 to 34 years old, indicating that a large number of women are infected during childbearing years. This study confirms that rubella infection represents an important Public Health problem in São Paulo city. The data on the seroprevalence of rubella antibodies before the mass vaccination campaign reflects the baseline immunological status of this population before any intervention and should be used to design an adequate vaccination strategy and to assess the seroepidemiological impact of this intervention.


Asunto(s)
Anticuerpos Antivirales/sangre , Virus de la Rubéola/inmunología , Rubéola (Sarampión Alemán)/epidemiología , Adolescente , Adulto , Brasil/epidemiología , Niño , Preescolar , Estudios Transversales , Sangre Fetal/inmunología , Humanos , Rubéola (Sarampión Alemán)/sangre , Estudios Seroepidemiológicos , Población Urbana
14.
Rev Inst Med Trop Sao Paulo ; 40(2): 65-70, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9755558

RESUMEN

A large epidemic of serogroup B meningococcal disease (MD), has been occurring in greater São Paulo, Brazil, since 1988. A Cuban-produced vaccine, based on outer-membrane-protein (OMP) from serogroup B: serotype 4: serosubtype P1.15 (B:4:P1.15) Neisseria meningitidis, was given to about 2.4 million children aged from 3 months to 6 years during 1989 and 1990. The administration of vaccine had little or no measurable effects on this outbreak. In order to detect clonal changes that could explain the continued increase in the incidence of disease after the vaccination, we serotyped isolates recovered between 1990 and 1996 from 834 patients with systemic disease. Strains B:4:P1.15, which was detected in the area as early as 1977, has been the most prevalent phenotype since 1988. These strains are still prevalent in the area and were responsible for about 68% of 834 serogroup B cases in the last 7 years. We analyzed 438 (52%) of these strains by restriction fragment length polymorphism (RFLPs) of rRNA genes (ribotyping). The most frequent pattern obtained was referred to as Rb1 (68%). We concluded that the same clone of B:4:P1.15-Rb1 strains was the most prevalent strain and responsible for the continued increase of incidence of serogroup B MD cases in greater São Paulo during the last 7 years in spite of the vaccination trial.


Asunto(s)
Infecciones Meningocócicas/epidemiología , Neisseria meningitidis/genética , Brasil/epidemiología , Niño , Preescolar , Humanos , Incidencia , Lactante , Infecciones Meningocócicas/microbiología , Infecciones Meningocócicas/prevención & control , Neisseria meningitidis/clasificación , Neisseria meningitidis/aislamiento & purificación , Prevalencia , Serotipificación
15.
Rev Soc Bras Med Trop ; 28(3): 211-4, 1995.
Artículo en Portugués | MEDLINE | ID: mdl-7480915

RESUMEN

During a six month period (June 1983 to January 1984), a case-control study was carried out to determine if the variables associated with domestic animals contact would be correlated with the prevalence of Toxoplasma gondii infection. A randomized sample of 500 subjects from the population of Ribeirão das Neves, Minas Gerais, Brazil was studied. A statistically significant correlation was found with cat, chicken and pig contact but none with consumption of meat, milk and eggs.


Asunto(s)
Animales Domésticos , Toxoplasmosis/epidemiología , Animales , Brasil/epidemiología , Humanos , Estudios Retrospectivos , Toxoplasmosis/transmisión
16.
Rev Soc Bras Med Trop ; 34(3): 299-300, 2001.
Artículo en Portugués | MEDLINE | ID: mdl-11460220

RESUMEN

During previous research on phlebotomine fauna in a settlement of the Brazilian National Agrarian Reform Institute (INCRA) on the Bodoquena Range, Mato Grosso do Sul State, Brazil, dogs were observed with clinical aspects suggestive of visceral leishmaniasis. A serological survey to leishmaniasis in 97 dogs, by indirect immunofluorescence test, showed 23 (23.7%) serum positive dogs. Samples of the parasites were identified as Leishmania (Leishmania) chagasi.


Asunto(s)
Enfermedades de los Perros/epidemiología , Leishmaniasis Visceral/veterinaria , Animales , Brasil , Perros , Leishmaniasis Visceral/epidemiología , Salud Rural
17.
Rev Saude Publica ; 33(6): 629-31, 1999 Dec.
Artículo en Portugués | MEDLINE | ID: mdl-10689382

RESUMEN

A serological survey was made in 973 stray dogs caught near green areas in S. Paulo county by the indirect immunofluorescence test. No positive serum was found, however autochthonous human cases of ACL that occurred in the county show the circulation of the parasite in the environment. This fact, associated with the existence of the vectors and the apparent absence of infected dogs in the areas studied, suggest that stray dog plays an insignificant role in the spread of the parasite. The cycle of the parasite in São Paulo county has been maintained by wild animals, hence the dog would be an accidental host just as humans.


Asunto(s)
Enfermedades de los Perros/epidemiología , Leishmaniasis Cutánea/veterinaria , Animales , Brasil/epidemiología , Enfermedades de los Perros/parasitología , Enfermedades de los Perros/transmisión , Perros , Técnica del Anticuerpo Fluorescente Indirecta , Leishmaniasis Cutánea/epidemiología , Leishmaniasis Cutánea/transmisión , Estudios Seroepidemiológicos
19.
Artículo en Inglés | MEDLINE | ID: mdl-24785726

RESUMEN

In this study the 13 polycyclic aromatic hydrocarbons (PAHs) identified as being genotoxic and carcinogenic by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) were determined in different brands of soybean oils available on the Brazilian market, totalling 42 samples. A solid-phase extraction (SPE) method for sample clean-up with a C18 cartridge, followed by reversed-phase HPLC with fluorescence detection, was used for determination. The method showed good recoveries for most PAHs studied with values between 74% and 111%. Good intra- and inter-day precisions (0.5 < RSD < 11.9) and high correlation coefficients (r(2)> 0.999) were obtained. The presence of PAHs was detected in all 42 samples with mean summed PAH levels ranging from 10.4 to 112.0 µg kg(-1). The mean and maximum dietary exposures for total PAHs were estimated as 12.4 and 19.1 ng kg bw(-1) day(-1), respectively.


Asunto(s)
Dieta , Exposición a Riesgos Ambientales , Contaminación de Alimentos/análisis , Hidrocarburos Policíclicos Aromáticos/análisis , Aceite de Soja/química , Brasil , Cromatografía Líquida de Alta Presión , Límite de Detección
20.
Clin Microbiol Infect ; 16(4): 369-78, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19456839

RESUMEN

The C-terminus of the Helicobacter pylori CagA protein is polymorphic, bearing different EPIYA sequences (EPIYA-A, B, C or D), and one or more CagA multimerization (CM) motifs. The number of EPIYA-C motifs is associated with precancerous lesions and gastric cancer (GC). The relationship between EPIYA, CM motifs and gastric lesions was examined in H. pylori-infected Colombian patients from areas of high and low risk for GC. Genomic DNA was extracted from H. pylori strains cultured from gastric biopsies from 80 adults with dyspeptic symptoms. Sixty-seven (83.8%) of 80 strains were cagA positive. The 3' region of cagA was sequenced, and EPIYA and CM motifs were identified. CagA proteins contained one (64.2%), two (34.3%) or three EPIYA-C motifs (1.5%), all with Western type CagA-specific sequences. Strains with one EPIYA-C motif were associated with less severe gastric lesions (non-atrophic and multifocal atrophic gastritis), whereas strains with multiple EPIYA-C motifs were associated with more severe lesions (intestinal metaplasia and dysplasia) (p <0.001). In 54 strains, the CM motifs were identical to those common in Western strains. Thirteen strains from the low-risk area contained two different CM motifs: one of Western type located within the EPIYA-C segment and another following the EPIYA-C segment and resembling the CM motif found in East Asian strains. These strains induced significantly shorter projections in AGS cells and an attenuated reduction in levels of CagA upon immunodepletion of SHP-2 than strains possessing Western/Western motifs. This novel finding may partially explain the difference in GC incidence in these populations.


Asunto(s)
Antígenos Bacterianos/genética , Proteínas Bacterianas/genética , Infecciones por Helicobacter/complicaciones , Helicobacter pylori/genética , Lesiones Precancerosas/microbiología , Neoplasias Gástricas/microbiología , Adulto , Secuencia de Aminoácidos , Antígenos Bacterianos/química , Antígenos Bacterianos/metabolismo , Proteínas Bacterianas/química , Proteínas Bacterianas/metabolismo , Colombia , Mucosa Gástrica/metabolismo , Mucosa Gástrica/microbiología , Helicobacter pylori/aislamiento & purificación , Helicobacter pylori/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Polimorfismo Genético , Lesiones Precancerosas/metabolismo , Lesiones Precancerosas/patología , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA